National Medical Care Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Abdulaziz Alobaid

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	5.9yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	5yrs

Son yönetim güncellemeleri

Recent updates

What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You

Dec 12

National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

Oct 29

National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue

Sep 25

Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Aug 06

Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely

Jul 26

National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

Apr 05

We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

Mar 14

National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Mar 13

Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Dec 27

Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

Dec 05

We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Aug 07

Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

May 29

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

May 08

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Dec 19

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Oct 19

National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

Aug 15

National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

May 13

Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 03

Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

Feb 09

National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Jan 27

Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)

Jan 14

Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?

Dec 25

Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 10

What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?

Nov 24

CEO

Abdulaziz Alobaid

5.9yrs

Görev süresi

Dr. Abdulaziz Saleh Alobaid serves as Chief Executive Officer at National Medical Care Company since January 1, 2019 and serves as its Managing Director since September 15, 2022. He was the Chief Medical O...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Badr Bin Fahad M. Al-Athel	Non Executive Director	no data	Veri yok	Veri yok
Saad Bin Abdulrahman Al-Fadly	Chairman of the Board	5.6yrs	Veri yok	Veri yok
Michael Davis	Vice Chairman	5.6yrs	Veri yok	Veri yok
Bashar Bin Abalkhail	Independent Director	no data	Veri yok	0.011% SAR 838.1k
Mashhor Bin Al-Obeikan	Independent Director	no data	Veri yok	Veri yok
Faraj bin Saad Al-Gabani	Non-Executive Director	3.4yrs	Veri yok	Veri yok
Mai Bint Al-Hoshan	Independent Director	no data	Veri yok	Veri yok
Sami Bin Al-Khashan	Independent Director	no data	Veri yok	Veri yok
Ahmed Bin Al-Qahtani	Non-Executive Director	4.5yrs	Veri yok	Veri yok

5.0yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: 4005 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2024/12/22 19:16
Gün Sonu Hisse Fiyatı	2024/12/22 00:00
Kazançlar	2024/09/30
Yıllık Kazançlar	2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

National Medical Care Company 12 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Ibrahim Elaiwat	Aljazira Capital Company
Jassim Al-Jubran	Aljazira Capital Company
Madhu Appissa	Al Rajhi Capital

National Medical Care Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Less than half of directors are independent

National Medical Care Company Announces Executive Appointments

National Medical Care Company, Annual General Meeting, Sep 06, 2022

Less than half of directors are independent

Recent updates

What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You

Now 22% overvalued

National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue

Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Second quarter 2024 earnings released: EPS: ر.س1.55 (vs ر.س1.07 in 2Q 2023)

New minor risk - Share price stability

Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely

Now 21% overvalued

National Medical Care Company Approves Cash Dividend for the Financial Period December 31, 2023, Payable on 12 June 2024

National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

Now 21% overvalued after recent price rise

We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Now 24% overvalued after recent price rise

Price target increased by 9.3% to ر.س196

Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Price target increased by 9.0% to ر.س165

Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

Price target increased by 8.5% to ر.س151

Consensus EPS estimates increase by 10%

Price target increased by 7.6% to ر.س144

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 16%

National Medical Care Company (SASE:4005) signed share purchase agreement to acquire Chronic Care Specialized Medical Hospital Company from Saudi Medical Care Group for SAR 193.21 million.

Second quarter 2023 earnings released: EPS: ر.س1.07 (vs ر.س0.94 in 2Q 2022)

We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Price target increased by 13% to ر.س103

National Medical Care Company (SASE:4005) completed the acquisition of Jiwar Medical Services Company from SmartMed.

Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

Investor sentiment improves as stock rises 18%

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Consensus EPS estimates increase by 11%

Investor sentiment improves as stock rises 20%

Price target increased by 14% to ر.س86.80

Full year 2022 earnings: EPS exceeds analyst expectations

National Medical Care Company (SASE:4005) signed a non-binding memorandum of understanding to acquire Jiwar Medical Services Company from SmartMed for SR 65 million.

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Less than half of directors are independent

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Now 20% undervalued

National Medical Care Company Announces Executive Appointments

Consensus EPS estimates increase by 16%

National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

Second quarter 2022 earnings released: EPS: ر.س0.94 (vs ر.س0.69 in 2Q 2021)

National Medical Care Company, Annual General Meeting, Sep 06, 2022

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: EPS and revenues miss analyst expectations

National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

Less than half of directors are independent

Now 20% undervalued

Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Full year 2021 earnings: EPS and revenues miss analyst expectations

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down

Third quarter 2021 earnings released: EPS ر.س0.74 (vs ر.س0.36 in 3Q 2020)

Second quarter 2021 earnings released: EPS ر.س0.69 (vs ر.س0.57 in 2Q 2020)

Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes

First quarter 2021 earnings released: EPS ر.س0.80 (vs ر.س0.74 in 1Q 2020)

Consensus forecasts updated

Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)

Full year 2020 earnings released: EPS ر.س2.17 (vs ر.س1.79 in FY 2019)

Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?

Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?

Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

New 90-day low: ر.س49.70

National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?